Financial reports
NT 10-Q
Notice of late quarterly filing
17 Aug 20
10-Q
2020 Q1
Quarterly report
6 May 20
10-K/A
2019 FY
Annual report (amended)
29 Apr 20
10-K
2019 FY
Annual report
3 Mar 20
10-Q
2019 Q3
Quarterly report
5 Nov 19
10-Q
2019 Q2
Quarterly report
6 Aug 19
10-Q
2019 Q1
Quarterly report
30 Apr 19
10-K
2018 FY
Annual report
26 Feb 19
10-Q
2018 Q3
Quarterly report
1 Nov 18
10-Q
2018 Q2
Quarterly report
7 Aug 18
Current reports
8-K
VIVUS Seeks Bankruptcy Court Approval of Second Amended Joint Chapter 11 Plan of Reorganization and Existing Stock Record Date
16 Nov 20
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
13 Jul 20
8-K
Entry into a Material Definitive Agreement
7 Jul 20
8-K
Regulation FD Disclosure
19 Jun 20
8-K
Entry into a Material Definitive Agreement
2 Jun 20
8-K
VIVUS Q1 2020 Earnings Conference Call
8 May 20
8-K
VIVUS Reports First Quarter 2020 Financial Results
6 May 20
8-K
VIVUS Announces Agreement with IEH Biopharma LLC Granting the Company a 30-Day Grace Period to Restructure its Corporate Debt
1 May 20
8-K
VIVUS Announces Closing of $11.55 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
3 Apr 20
8-K
Entry into a Material Definitive Agreement
2 Apr 20
Registration and prospectus
15-12B
Securities registration termination
8 Jan 21
S-8 POS
Registration of securities for employees (post-effective amendment)
30 Dec 20
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Dec 20
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Dec 20
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Dec 20
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Dec 20
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Dec 20
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Dec 20
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Dec 20
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Dec 20
Proxies
DEFA14A
Additional proxy soliciting materials
17 Apr 19
DEF 14A
Definitive proxy
17 Apr 19
DEF 14A
Definitive proxy
1 Aug 18
PRE 14A
Preliminary proxy
18 Jul 18
DEF 14A
Definitive proxy
27 Sep 17
PRE 14A
Preliminary proxy
8 Sep 17
DEF 14A
Definitive proxy
5 Oct 16
DEF 14A
Definitive proxy
18 Sep 15
DEF 14A
Definitive proxy
15 Aug 14
DEFA14A
Additional proxy soliciting materials
26 Jul 13
Other
EFFECT
Notice of effectiveness
31 Dec 20
EFFECT
Notice of effectiveness
31 Dec 20
CT ORDER
Confidential treatment order
3 Aug 20
CT ORDER
Confidential treatment order
23 Jul 20
CT ORDER
Confidential treatment order
24 Apr 20
CT ORDER
Confidential treatment order
12 Mar 20
CT ORDER
Confidential treatment order
13 Dec 19
CT ORDER
Confidential treatment order
14 Nov 19
CT ORDER
Confidential treatment order
19 Mar 19
CT ORDER
Confidential treatment order
19 Mar 19
Ownership
SC 13G/A
SABBY MANAGEMENT, LLC
5 Jan 21
SC 13G
ARMISTICE CAPITAL, LLC
13 Apr 20
SC 13G
INTRACOASTAL CAPITAL, LLC
10 Apr 20
SC 13G
SABBY MANAGEMENT, LLC
1 Apr 20
4
HERM ROSENMAN
24 Feb 20
4
Jorge MD Plutzky
24 Feb 20
4
David Y Norton
24 Feb 20
4
THOMAS BRAXTON KING
24 Feb 20
4
EDWARD A KANGAS
24 Feb 20
4
Karen E. Ferrell
24 Feb 20